MPI DTPA KIT - CHELATE
LOE ApproachingNDAINJECTIONINJECTABLE
Approved
Apr 1976
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 1h ago · AI intelligence enriched 3w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
MPI DTPA KIT - CHELATE is an injectable diagnostic imaging agent used in nuclear medicine procedures. It is a chelation kit designed to bind with radiotracers for diagnostic imaging purposes. The product enables visualization of organ function and perfusion in clinical diagnostic settings.
LOE Approaching
Product approaching loss of exclusivity with modest competitive pressure (30%), suggesting defensive positioning and smaller team focus on cost management and market maintenance.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
With 1,098 linked job opportunities, this product supports careers primarily in technical infrastructure, customer-facing operations, and business development rather than traditional pharmaceutical roles. The non-traditional role mix reflects GE HealthCare's broader healthcare technology platform and the diagnostic nature of this injectable product.
Sr. Network Provisioning Analyst
Worked on MPI DTPA KIT - CHELATE at GE HealthCare? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.